Patents and Trademarks
TheraCell Patents
US Patents: US 9,486,557, US 9,572,912
US Patents: US 9,486,557, US 9,572,912
US Patents: US 9,486,557, US 9,572,912
US Patents: US 9,486,557, US 9,572,912
US Patents: US 9,486,557, US 9,572,912, US 10,610,366
US Patents: US 9,486,557, US 9,572,912, US 10,639,157, US 10,987,224
US Patents: US 9,486,557, US 9,572,912
US Patents: US 9,486,557, US 9,572,912
Allosource and NuVasive Patents
AlloSource is a licensee of the following patents (US 9,486,557, US 9,572,912) and produces products using TheraCell's demineralized bone (DBF ) technology. They also distribute products as well as providing products to other distributors (NuVasive). Australian Biotechnologies Inc.is a licensee of AUS 2014253753 and produces products using TheraCell's DBF technology. One or more implants, instruments, and/or techniques associated with the product names below may be covered by one or more of the United States Patents indicated:
AlloFuse® Cortical Fibers
US Patents: US 9,486,557, US 9,572,912
AlloFuse® Fiber Boat
US Patents:US 9,486,557, US 9,572,912
Propel® DBM Fibers
US Patents: US 9,486,557, US 9,572,912
Propel® Fiber Boat
US Patents: US 9,486,557, US 9,572,912
Patent Portfolio – Enhanced Cancellous Sponge
AlloSource is a licensee of the following patents (US 9,636,436) and produces products using TheraCell's enhanced cancellous technology. Australian Biotechnologies Inc.is a licensee of AUS 2014235352 and produces products using TheraCell's enhanced cancellous technology. One or more implants, instruments, and/or techniques associated with the product names below may be covered by one or more of the United States Patents indicated:
AlloFlex® Plus
US Patents: US 9,636,436
Patent Portfolio – Demineralized Bone Fiber Based Product
In addition to the patents cited above Theracell has worked diligently to file a number of patent applications to cover enhancements to the base DBF technology and specific procedure specific products.
Patent Portfolio - Oxygenation
US 8,859,007, US 9,308,295, AUS 2014205119, US 9,687,589
Biologica Technologies Patents
ProteiOS
US Patents: 10,357,594
OsseoGEN
US Patents: 10,286,112, 10,660,986, & 11,253,631